Efficacy in vivo of a cancer therapy strategy combining HSV1716 mediated oncolysis with gene transfer and targeted radiotherapy
Sorensen, Annette and Mairs, Robert J. and Braidwood, Lynne and Joyce, Craig and Conner, Joe and Pimlott, Sally and Brown, S. Moira and Boyd, Marie (2012) Efficacy in vivo of a cancer therapy strategy combining HSV1716 mediated oncolysis with gene transfer and targeted radiotherapy. Mutagenesis, 27 (1). pp. 134-135. ISSN 0267-8357 (https://doi.org/10.1093/mutage/ger068)
Full text not available in this repository.Request a copyAbstract
Oncolytic herpes viruses have show promise for the treatment of cancer however it is unlikely that the optimal application of these viruses will be as single therapeutic agents. An alternative strategy would be to utilise these viruses to deliver therapeutic transgenes and enhance their tumour cell killing capacity.
ORCID iDs
Sorensen, Annette ORCID: https://orcid.org/0000-0002-1861-7258, Mairs, Robert J., Braidwood, Lynne, Joyce, Craig, Conner, Joe, Pimlott, Sally, Brown, S. Moira and Boyd, Marie ORCID: https://orcid.org/0000-0003-4120-2218;-
-
Item type: Article ID code: 40170 Dates: DateEvent2012PublishedKeywords: cancer therapy, oncolysis, gene transfer, Pharmacy and materia medica, Genetics, Genetics(clinical), Health, Toxicology and Mutagenesis, Toxicology, SDG 3 - Good Health and Well-being Subjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Technology and Innovation Centre > Advanced Science and Technology
Technology and Innovation Centre > BionanotechnologyDepositing user: Pure Administrator Date deposited: 22 Jun 2012 10:04 Last modified: 01 Nov 2023 09:56 URI: https://strathprints.strath.ac.uk/id/eprint/40170
CORE (COnnecting REpositories)